Griffon Pharmaceuticals appoints Dr. Marc Cluzel to Board of Directors
11 déc. 2018 07h00 HE
|
Griffon Pharmaceuticals
MONTREAL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Montreal-based biopharmaceutical company Griffon Pharmaceuticals Inc. (“Griffon”) announced today that Marc Cluzel, MD, PhD, joins the company’s Board of...
Metreleptin and Lipodystrophy Data Presented at the International Meeting of Pediatric Endocrinology
15 sept. 2017 08h30 HE
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...